ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.51
+0.14 (2.61%)
Dec 20, 2024, 4:00 PM EST - Market closed
ENDRA Life Sciences Employees
ENDRA Life Sciences had 21 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$419,928
Market Cap
2.96M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Regional Health Properties | 114 |
| iSpecimen | 53 |
| Matinas BioPharma Holdings | 32 |
| Scinai Immunotherapeutics | 31 |
| LogicMark | 27 |
| Windtree Therapeutics | 20 |
| Catheter Precision | 14 |
| Entero Therapeutics | 9 |
NDRA News
- 4 weeks ago - ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire
- 5 weeks ago - ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire
- 5 weeks ago - Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024 - Business Wire
- 6 weeks ago - ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent - Business Wire
- 2 months ago - ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany - Business Wire
- 4 months ago - Data I/O And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
- 4 months ago - ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements - Business Wire
- 4 months ago - ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript - Seeking Alpha